These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 3065058)

  • 1. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Sorkin EM; Clissold SP
    Drugs; 1987 Apr; 33(4):296-345. PubMed ID: 3297616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.
    Murdoch D; Heel RC
    Drugs; 1991 Mar; 41(3):478-505. PubMed ID: 1711448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
    Langtry HD; Spencer CM
    Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications.
    Katz AM; Leach NM
    J Clin Pharmacol; 1987 Nov; 27(11):825-34. PubMed ID: 3323259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.
    Brogden RN; McTavish D
    Drugs Aging; 1995 Feb; 6(2):150-71. PubMed ID: 7711361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
    Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
    Brogden RN; Markham A
    Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
    Hamilton SF; Houle LM; Thadani U
    Heart Dis; 1999; 1(5):279-88. PubMed ID: 11720635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nisoldipine: a new dihydropyridine calcium-channel blocker.
    Mitchell J; Frishman W; Heiman M
    J Clin Pharmacol; 1993 Jan; 33(1):46-52. PubMed ID: 8429113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina.
    Crean PA; Waters DD; Lam J; Chaitman BR
    Am Heart J; 1987 Feb; 113(2 Pt 1):261-5. PubMed ID: 3544754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of amlodipine in myocardial ischaemia.
    Taylor SH
    Postgrad Med J; 1991; 67 Suppl 5():S48-51. PubMed ID: 1839440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
    Sorkin EM; Clissold SP; Brogden RN
    Drugs; 1985 Sep; 30(3):182-274. PubMed ID: 2412780
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients.
    Lopez LM; Rubin MR; Holland JP; Mehta JL
    Am Heart J; 1985 Nov; 110(5):991-6. PubMed ID: 3933316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
    Fodor JG
    Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():873-9. PubMed ID: 9126676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A haemodynamic study of the effects of combined slow-calcium channel blockade (nisoldipine) and beta-blockade (metoprolol) in coronary heart disease.
    Silke B; Verma SP; Midtbo KA; Müller P; Frais MA; Reynolds G; Taylor SH
    Int J Cardiol; 1986 Nov; 13(2):231-41. PubMed ID: 3793280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of nisoldipine combined with beta-adrenergic-blocking drugs in the treatment of chronic stable angina.
    O'Keefe JC; Creamer JE; Banim SO
    Clin Cardiol; 1987 Jun; 10(6):345-50. PubMed ID: 2885117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute effects of nisoldipine in patients with stable effort angina].
    De Caprio L; Acanfora D; Papa M; Gallucci F; Leosco D; Covelluzzi F; Borgnino C; Cicatiello M; Cosentino F; Rengo F
    Cardiologia; 1988 Oct; 33(10):985-8. PubMed ID: 3069205
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
    Lancaster SG; Sorkin EM
    Drugs; 1988 Sep; 36(3):256-85. PubMed ID: 2903820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
    Murdoch D; Brogden RN
    Drugs; 1991 May; 41(5):737-79. PubMed ID: 1712708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.